|
|
|
| Join 1,000+ pharma, biotech, and drug delivery professionals at the PODD: Partnership Opportunities in Drug Delivery Conference, October 27–28 in Boston. Featuring 10 technology tracks, pharma company spotlights, 1:1 partnering, and more. Attendees will also hear from leaders at companies including AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GSK, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, and others. Register at PODDConference.com with code LSL20 for 20% off. |
|
|
|
|
By Drug Delivery Leader: Sit and Deliver | Not only do opioid overdose sufferers need urgent, rescue treatments but they often remain vulnerable to symptom rebound and continued opioid use disorder (OUD). In this episode of Sit and Deliver, Tom Jenkins, Chief Scientific Officer of biopharmaceutical company Elysium Therapeutics, talks with videocast host Tom von Gunden about mitigating recurrence by using long-acting, intramuscular injectables (LAIs) to deliver the rescue drug naloxone in a rapid onset, slow-off formulation. | |
|
|
Understanding The Global Regulatory Landscape For Combination Products | By Drug Delivery Leader: The Combination Products Handbook | In this videocast episode, host Tom von Gunden discusses Chapter 14 of The Combination Products Handbook (CRC Press) with the book’s editor Susan Neadle, along with chapter coauthors Stephanie Goebel, Cherry Malonzo Marty, and Viky Verna. The group provides overviews of the commonalities and variances in regulatory definitions and guidances for combination products across global jurisdictions and agencies. |
|
|
|
|
| Developing A 'Human Solution' To Autoinjector Design | Poster | By Jonathan Bradshaw, Oval Medical Technologies, SMC Ltd. | Delivering high viscosity (HV) formulations with a truly human solution involves a balance between safety and practicality. Learn the importance of achieving this solution with HV autoinjector design. |
|
|
|
|
| Key Considerations For Dry Powder Inhalation | Article | By Carolyn Berg and Carla Vozone, Catalent | Advancements in dry powder inhalation require specialized expertise. Commercialization depends on a partner that can seamlessly manage complex formulation, scale-up, and regulatory compliance. |
|
|
|
|
|
|
| AAPS PharmSci 360 delivers research spanning the pharmaceutical pipeline, from discovery to manufacturing to delivery. Thousands of scientists and decision-makers from across the globe converge to discuss cutting-edge breakthroughs, technologies, and techniques at this science-first event. Join your colleagues for the latest in pharmaceutical science in San Antonio, Texas, November 9-12, 2025. Register today! |
|
|
|
|
|
|
.png){kind=logo}
